PCI and Coronary Stents in China: Decisions and Recovery

Understand PCI benefit, lesion and stent planning, complex coronary decisions, dual antiplatelet therapy, recovery and cross-border follow-up.

Key takeaways

PCI can reopen a blocked coronary artery during an acute heart attack; in selected stable disease it can relieve angina that limits daily life. A narrowing visible on a scan, by itself, says little about what an individual patient stands to gain.
A plan that says “one stent” leaves most of the decision out. Which vessel, lesion length, calcification, a bifurcation, a chronic total occlusion, stent dimensions, imaging guidance and disease left untreated — all of these shape the procedure and how durable the result is.
Antiplatelet treatment after a coronary stent belongs to the procedure itself; skipping it undoes the stent's protection. How long it continues, and which drugs are used, depends on whether the event was acute or stable and on the balance between clotting and bleeding risk.
Travelling for treatment? Before you go, confirm that the antiplatelet medicines you will need are available and affordable at home. Dental work, surgery, a bleeding scare or the trip itself — any pause in these drugs needs a plan agreed with your clinicians, never a solo decision.

Full guide

Percutaneous coronary intervention (PCI) treats a narrowed or blocked coronary artery through a catheter. The usual sequence is to open a small balloon at the lesion and then deploy a mesh stent to hold the lumen open.[1] The chest is never cut open, yet PCI remains an invasive cardiovascular procedure, and what it commits you to — medicines, follow-up — outlasts the puncture site by a long time.

Brand names matter far less than three other questions: should this artery be opened now, what clinical outcome is expected from doing it, and can the patient actually complete the medicines and follow-up that keep the result protected.

Name the clinical setting before comparing PCI offers

One word — “stent” — gets attached to some very different situations:

Acute coronary syndrome (ACS): a plaque ruptures without warning, a clot forms, and heart muscle comes under threat. Here PCI can be an emergency way to get blood flowing again.
Chronic coronary disease with angina: PCI enters the discussion when symptoms stay unacceptable on appropriate medicines, or when the anatomy and ischaemia findings point to a specific gain.
Incidentally discovered stenosis: a narrowing that shows up on imaging may have nothing to do with the symptoms, and a picture alone never makes intervention necessary.
Previous PCI failure or recurrent disease: the cause could be in-stent restenosis, stent thrombosis, disease at a stent edge or trouble in another vessel — each one needs its own explanation.

The 2023 chronic coronary disease guideline puts patient-centred decisions, lifestyle measures and preventive treatment first, and it discourages routine repeat anatomical or ischaemia testing when symptoms and functional status are unchanged.[2] Keep one distinction in view: PCI treats a particular flow-limiting problem. The underlying tendency to atherosclerosis, running through the whole coronary circulation, stays.

Ask the cardiologist to finish one sentence: “For this patient, PCI is intended to ___.” Decent answers sound like: rescue threatened heart muscle, reduce angina, improve exercise capacity, deal with a high-risk anatomical situation. If all you get is “because it is 70%,” the reasoning has not been finished.

Decide whether PCI, surgery or medical therapy is the better route

Anatomy decides less than people expect. Diabetes, how well the heart pumps, kidney disease, frailty, bleeding risk, previous bypass grafts, other surgery on the calendar, what the patient actually wants — all of it feeds into the choice. When the left main is significantly diseased, several vessels are complex, or the best strategy is genuinely unclear, guidelines call for a multidisciplinary Heart Team discussion.[3]

Before you agree to an elective procedure, ask:

If I stay on medicines alone, what happens?
What benefit should PCI bring me, and on what time frame?
Would coronary bypass surgery be a reasonable alternative in my case?
Will every important lesion be treated this time, or is the plan deliberately staged?
What finding would make the operator stop and ask for another opinion?

You should get time with these questions before any sedation. When PCI is proposed straight after the diagnostic angiogram, consent needs to be specific to you and obtained early enough for real questions — a signature collected once the catheter is already in place carries little weight.[4]

The lesion determines the tools

A proper estimate describes the coronary problem itself; the stent count is only the tail end of that. Ask which of these the target looks like:

short and simple, or long and diffuse;
heavily calcified, so plaque modification is likely;
on a bifurcation that involves an important side branch;
a chronic total occlusion;
in the left main, a small vessel, an old stent or a bypass graft; or
accompanied by other lesions whose functional importance is unclear.

For lesions that look intermediate, a pressure-wire measurement — FFR or iFR — can show whether they actually restrict flow. Intravascular ultrasound (IVUS) and optical coherence tomography (OCT) look at the artery from the inside: vessel size, plaque, calcium, stent expansion, edge problems. The 2025 ACS guideline gives intravascular imaging a strong role in guiding PCI, particularly where the quality of the result matters most.[5]

None of this guarantees success, and a straightforward lesion rarely needs the full toolkit. Ask it this way: “What uncertainty will this tool resolve in my case?” On paper, the estimate should itemise guidewires, balloons, stents, imaging or physiology catheters, calcium-modification devices, contrast, professional fees and the cost of possible extra nights.

What the PCI procedure involves

PCI happens in a catheterisation laboratory, with ECG, blood pressure and oxygen monitored throughout. The wrist or groin gets local anaesthetic, and many patients stay awake under light sedation. Working through an arterial sheath, the operator passes a guiding catheter up toward the heart and threads a fine wire across the lesion. A balloon then prepares or expands the narrowed segment, a stent mounted on a balloon is opened against the artery wall, and sometimes a further balloon inflation tidies up the result.

For PCI in ACS and in stable ischaemic disease, guidelines prefer radial access at the wrist where appropriate, because it bleeds less and causes fewer vascular complications than femoral access at the groin.[3] The groin still gets used — for difficult anatomy, larger equipment or circulatory support. Your team should be able to tell you why they picked one route over the other.

While the balloon is inflated, blood flow drops briefly and chest pressure is common — that part is expected. What staff need to hear about straight away is new pain, trouble breathing, nausea, itching or any neurological symptom. Anticoagulant and antiplatelet medicines are used during the procedure, and the more complex the lesion, the more contrast, radiation and time the job usually takes.

A drug-eluting stent is an implant, not a cure

Most current coronary stents carry a medicine that limits tissue overgrowing inside them,[1] and the implant stays in the artery for good. The procedure record should name the manufacturer, model, diameter, length, lot or device identifiers where available, the exact vessel segment, deployment pressure, post-dilation and final flow — and it should say which residual disease was deliberately left alone.

In the early phase the hazards are bleeding, injury to the access vessel, contrast reaction or kidney injury, coronary dissection or perforation, loss of a side branch, arrhythmia, heart attack, stroke and, very rarely, death. Later on, the concerns shift to restenosis, stent thrombosis and disease progressing elsewhere. How likely any of this is varies enormously — an uncomplicated elective single-vessel PCI is a different proposition from emergency treatment in shock. A generic percentage tells you little; ask about your own situation.

China's current clinical-application standard for cardiovascular intervention requires suitable institutions, trained personnel, equipment, quality systems and emergency capability.[6] That is the floor. For a complex elective PCI, also ask how much experience the operator has with that lesion type, what surgical or transfer backup exists, what intensive-care support is on site and how the unit audits its complications.

Antiplatelet treatment protects the stent

Until the artery heals over it, a stent is a surface where a dangerous clot can form. That is what dual antiplatelet therapy (DAPT) is for: usually aspirin plus a P2Y12 inhibitor — clopidogrel, ticagrelor or prasugrel.[7]

How long this lasts differs from person to person. The 2025 ACS guideline recommends at least 12 months after discharge for many ACS patients whose bleeding risk is not high, and lays out alternative strategies for those at higher bleeding risk.[5] For selected stable-disease patients, current guidance permits shorter DAPT and a move to a single antiplatelet drug once ischaemic and bleeding risks have been weighed.[2][3]

Before the PCI happens, the discharge plan should already answer:

the exact generic names, doses and dosing times;
how long the two-drug phase lasts and how long the one-drug phase;
what to do about a missed or vomited dose;
interactions that matter, including non-prescription anti-inflammatory drugs;
who is allowed to approve any interruption;
which bleeding means urgent care; and
whether the same formulation can be reliably obtained back home.

Some patients also take long-term anticoagulation — for atrial fibrillation, a mechanical valve, venous thrombosis or another reason — and combining that with DAPT is specialist work. A prescription that just says “take all three blood thinners”, with no dates, is unsafe.

Bruising, a prescription running out, a dentist's request, another surgeon's preference — none of these justifies stopping on your own. Any change belongs with the cardiologist who knows the stent timing and the thrombosis risk, coordinating with whoever is managing the procedure or the bleeding.[7]

Recovery is also secondary prevention

Afterwards, the team watches for recurrent chest symptoms, rhythm problems, circulation beyond the puncture site and bleeding, plus kidney or heart status where that matters. Selected elective cases go home the same day; after ACS, a complex intervention or a complication, the stay is longer.

The stent repairs one segment. Everything else — cholesterol-lowering treatment, blood-pressure and diabetes management, stopping smoking, physical activity, nutrition and, where indicated, cardiac rehabilitation — is what lowers risk over the long term.[2] Ask for a rehabilitation referral you can actually use at home and a staged return-to-activity plan; “just rest” is too vague to act on.

New or persistent chest pressure, marked breathlessness, fainting, stroke symptoms, puncture-site bleeding you cannot control, a rapidly expanding swelling, a hand or leg that turns cold, pale or numb — any of these means urgent local care. Waiting for an international reply is the wrong move when a possible heart attack or major bleed is happening.

Build a cross-border stent record

Before you leave the treating hospital, collect:

the diagnostic angiography and PCI reports, plus the full image study;
identifiers, sizes and implanted locations for the stent and any other devices;
the IVUS/OCT or FFR/iFR findings, if any of those were used;
how much contrast was used, the access route and any complication;
baseline and discharge ECG and echocardiogram, plus relevant laboratory results;
the exact discharge medicines, with stop or review dates;
what residual coronary disease remains and the plan for any staged procedure;
fitness-to-fly advice and activity limits; and
named contacts for questions about the procedure and the medicines.

Where possible, send all of this to your home cardiologist before you fly. A stent card helps; the procedure report, the images and the medication plan are what the next doctor really needs.

Medical disclaimer: This article is general education, not a recommendation for PCI or for any specific antiplatelet regimen. Possible heart-attack symptoms, major bleeding or changes in limb circulation need immediate local medical care.

FAQ

Does a 70% coronary narrowing always need a stent?

No — not by itself. Symptoms, whether the presentation is acute or chronic, ischaemia, vessel and lesion anatomy, medical therapy, heart function and the alternatives all feed the decision.[2][3] A percentage read off one image is only part of that assessment.

What is the difference between balloon angioplasty and a stent?

The balloon does a temporary job: it expands the narrowed segment. A stent is a mesh implant pressed open against the vessel wall to help hold the lumen open afterwards, and modern stents usually release a medicine that limits tissue regrowth.[1]

How long must dual antiplatelet therapy continue?

It depends on the person. Many ACS patients at lower bleeding risk are advised to stay on DAPT for at least 12 months; selected patients at higher bleeding risk, or with stable disease, may follow shorter strategies under specialist guidance.[2][5] Whatever the plan, the discharge record should spell out exact drugs and dates.

Can I pause antiplatelet medicine for dental work or surgery?

Only with coordinated advice. Stop too early and a clot can form inside the stent.[7] The interventional cardiologist and whoever is planning the dental or surgical work need to weigh thrombosis against bleeding risk together and put the plan in writing.